Facilities Engineering Senior Specialist

Responsibilities

• Drive continuous improvement of manufacturing assets and reliability engineering programs through root cause analysis and maintenance planning.
• Develop and implement asset life cycle management strategies from procurement through decommissioning.
• Collaborate with FacOps to lead the development of asset maintenance plans based on reliability assessments and field walk downs.
• Perform spare parts assessments to determine critical spares and recommended stock levels to minimize unplanned downtime.
• Conduct Root Cause Analysis (RCA) on equipment to prevent future failures and reduce downtime.
• Develop and advance Reliability Engineering KPIs to improve equipment reliability and decision-making.
• Monitor equipment performance metrics to analyze data and predict potential failures.
• Ensure compliance with GMP guidelines and support regulatory activities.

Requirements

• Bachelor's degree in Mechanical, Chemical, or Industrial Engineering, or a related field.
• 3 years of experience in Facilities Engineering or a related specialist occupation.
• Demonstrable experience executing Reliability Engineering tasks, including Root Cause Analysis (RCA).
• Experience with reliability assessments and understanding failure modes.
• Experience performing spare parts assessments, including guidance on critical spares and quantities.
• Experience developing and maturing reliability engineering KPIs in line with industry standards.
• Knowledge of GMP guidelines and Good Engineering Practices.

Benefits

• Medical, dental, and vision benefits.
• Generous paid time off, including a week-long company shutdown in the Summer and Winter.
• Educational assistance programs, including student loan repayment.
• 401(k) with company matching.
• Annual bonus and annual equity awards eligibility.
• Commuting subsidies and charitable donation matching.

About the Company

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company is dedicated to treating the underlying causes of multiple chronic, life-shortening genetic diseases and continues to advance a robust clinical pipeline across various modalities.